Allentown, PA – February, 2023 – OCLI Vision and Spectrum Vision Partners are delighted to announce the acquisition of Bausch Eye Associates. The multi-specialty ophthalmology practice consists of Andrew N. Bausch, MD, and Steven J. Kanoff, MD. Bausch Eye Associates brings the number of OCLI Vision clinic locations to 14 in the Pennsylvania region.
OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmologists, optometrists and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia. Bausch Eye Associates is Spectrum’s 23rd affiliation since 2017.
“I’m very excited to welcome the exceptional eye doctors and surgeons at Bausch Eye Associates to the OCLI Vision Team,” noted Tom Burke, SVP’s CEO. “The practice is an outstanding addition to our growing network in the Lehigh Valley region, which includes Valley Eye Surgery Center (VESC), in Bethlehem. Dr. Bausch has been one of our highly regarded partner surgeons at VESC the premier, eye surgery only surgery center, serving the Lehigh Valley community. All our partners at VESC are proud to work with Dr. Bausch and his lay management team. We look forward to our continued delivery of exceptional eye care at Bausch Eye Associates, OCLI Vision and VESC, along with our esteemed partners at Lehigh Valley Eye Center|OCLI Vision, also located in Allentown.”
The experienced team at Bausch Eye Associates provides first-class patient focused care across various ophthalmic disciplines. The office is located at 1616 West Allen Street in Allentown, PA.
“OCLI Vision is known for their tremendous work in the ophthalmic field. Aligning with such a great group will allow us to provide even higher levels of care to the patients we dutifully serve,” noted Dr. Bausch.
For questions or further information regarding the OCLI Vision team or Spectrum Vision Partners, please contact:
Chief Executive Officer
Chief Development Officer
About OCLI Vision
Founded in 1997, OCLI Vision (www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP) (www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,400 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 40 clinic locations, five state-licensed ambulatory surgery centers, and over 125 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.
About Blue Sea Capital
Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies valued up to $250 million. The firm has more than $750 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare, and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.